Published in Antimicrob Agents Chemother on June 01, 1988
Pharmacokinetic evaluation of two dosage regimens of clindamycin phosphate. Antimicrob Agents Chemother (1989) 1.00
Defining criteria for the pharmacoeconomic evaluation of new oral cephalosporins. Pharmacoeconomics (1994) 0.75
Therapy of obstetrical infections with moxalactam. Antimicrob Agents Chemother (1980) 1.64
Economic analysis of a new drug: potential savings in hospital operating costs from the use of a once-daily regimen of a parenteral cephalosporin. Rev Infect Dis (1985) 1.06
A randomized clinical trial of moxalactam alone versus tobramycin plus clindamycin in abdominal sepsis. Ann Surg (1983) 1.06
A double-blind, randomized comparison of clindamycin-gentamicin versus cefamandole for treatment of post-cesarean section endomyometritis. Am J Obstet Gynecol (1982) 1.05
The influence of dose frequency and agent toxicity on the cost of parenteral antibiotic therapy. Drug Intell Clin Pharm (1982) 0.96
Pathophysiology and management of postcesarean endomyometritis. Obstet Gynecol (1986) 0.95
A double-blind, randomized comparison of moxalactam versus clindamycin-gentamicin in treatment of endomyometritis after cesarean section delivery. Am J Obstet Gynecol (1983) 0.90
Twice-daily moxalactam versus gentamicin and clindamycin in patients with penetrating abdominal trauma. Clin Pharm (1985) 0.83
Randomized, comparative trial of imipenem/cilastatin and moxalactam in the treatment of serious obstetric and gynecologic infections. Surg Gynecol Obstet (1986) 0.81
Moxalactam for treatment of pelvic infections after cesarean delivery. Rev Infect Dis (1983) 0.81
Cost comparison of two antimicrobial regimens for treating mixed aerobic-anaerobic infections. Am J Hosp Pharm (1981) 0.81
Moxalactam versus clindamycin plus tobramycin in the treatment of obstetric and gynecologic infections. Am J Obstet Gynecol (1985) 0.81
Controversies in antimicrobial therapy: pitfalls in monitoring aminoglycoside therapy. Am J Hosp Pharm (1986) 0.79
Comparison of moxalactam with the combination of clindamycin and an aminoglycoside in the treatment of common surgical infections. Rev Infect Dis (1983) 0.79
Cefoxitin versus clindamycin and gentamicin in the treatment of postcesarean section infections. Obstet Gynecol (1986) 0.79
Comparative clinical evaluation of ticarcillin plus clavulanic acid versus clindamycin plus gentamicin in treatment of post-cesarean endomyometritis. Am J Med (1985) 0.78
Cost containment of reconstituted parenteral antibiotics: personnel and supply costs associated with preparation, dispensing, and administration. Rev Infect Dis (1985) 0.78
Contamination rates and costs associated with the use of four intermittent intravenous infusion systems. Am J Hosp Pharm (1979) 0.78
Cost of intravenous antibiotic therapy. Frequency of administration as a factor. Postgrad Med (1983) 0.78
Cost-containment of antimicrobial therapy. Drug Intell Clin Pharm (1985) 0.78
Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med (1995) 8.89
Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis (1997) 6.64
A randomized placebo-controlled trial of erythromycin for the treatment of Ureaplasma urealyticum to prevent premature delivery. The Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol (1991) 2.33
Characteristics of three vaginal flora patterns assessed by gram stain among pregnant women. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol (1992) 2.27
Quantitative bacteriology of amniotic fluid from women with clinical intraamniotic infection at term. J Infect Dis (1982) 2.17
Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group. Am J Obstet Gynecol (1996) 2.16
Management of genital herpes infection in pregnancy. Obstet Gynecol (1988) 1.80
Preventing neonatal herpes--current strategies. N Engl J Med (1992) 1.67
Therapy of obstetrical infections with moxalactam. Antimicrob Agents Chemother (1980) 1.64
Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant. J Infect Dis (1979) 1.55
Adverse perinatal outcome and resistant Enterobacteriaceae after antibiotic usage for premature rupture of the membranes and group B streptococcus carriage. Obstet Gynecol (1993) 1.45
Risk factors for perinatal group B streptococcal disease after amniotic fluid colonization. Am J Obstet Gynecol (1990) 1.42
Evidence relating bacterial vaginosis to intraamniotic infection. Am J Obstet Gynecol (1989) 1.34
Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol (1998) 1.32
Is penicillin G a better choice than ampicillin for prophylaxis of neonatal group B streptococcal infections? Obstet Gynecol (1994) 1.30
Clinical risk factors for puerperal infection. Obstet Gynecol (1980) 1.26
Intraamniotic infection in low-birth-weight infants. J Infect Dis (1988) 1.26
Risk factors for preterm premature rupture of fetal membranes: a multicenter case-control study. Am J Obstet Gynecol (1990) 1.25
The genital flora of women with intraamniotic infection. Vaginal Infection and Prematurity Study Group. J Infect Dis (1995) 1.22
A clinical and microbiologic analysis of risk factors for puerperal endometritis. Obstet Gynecol (1990) 1.19
Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion. J Clin Oncol (1994) 1.18
Polymerase chain reaction-based genotyping for allotypic markers of immunoglobulin kappa shows allelic association of Km with kappa variable segment. Genomics (1992) 1.16
Premature rupture of the membranes. Obstet Gynecol (1982) 1.14
Life-threatening puerperal infection due to group A streptococci. Obstet Gynecol (1992) 1.12
Logistic regression analysis of risk factors for intra-amniotic infection. Obstet Gynecol (1989) 1.11
Infection after cesarean section. Clin Obstet Gynecol (1985) 1.09
Antibiotic therapy of endometritis following cesarean section. Treatment successes and failures. Obstet Gynecol (1978) 1.08
Puerperal endometritis: a prospective microbiologic study. Am J Obstet Gynecol (1975) 1.08
Taxol: a history of pharmaceutical development and current pharmaceutical concerns. J Natl Cancer Inst Monogr (1993) 1.07
Pelvic vein thrombophlebitis: diagnostic dilemma and therapeutic challenge. Obstet Gynecol Surv (1983) 1.07
Role of Ureaplasma urealyticum in amnionitis. Pediatr Infect Dis (1987) 1.06
Microbiology of the female genital tract. Am J Obstet Gynecol (1987) 1.06
Prophylactic antibiotics in cesarean section: a double-blind study. Am J Obstet Gynecol (1972) 1.05
A double-blind, randomized comparison of clindamycin-gentamicin versus cefamandole for treatment of post-cesarean section endomyometritis. Am J Obstet Gynecol (1982) 1.05
Clinical comparison of single-oral-dose cefuroxime axetil and amoxicillin with probenecid for uncomplicated gonococcal infections in women. Antimicrob Agents Chemother (1989) 1.02
Histologic inflammation in the maternal and fetal compartments in a rabbit model of acute intra-amniotic infection. Am J Obstet Gynecol (2000) 1.02
Internal fetal monitoring and maternal infection following cesarean section. A prospective study. Obstet Gynecol (1978) 1.02
Placental transfer of clindamycin and gentamicin in term pregnancy. Am J Obstet Gynecol (1976) 1.01
Amniotic fluid tumor necrosis factor-alpha and interleukin-1 in a rabbit model of bacterially induced preterm pregnancy loss. Am J Obstet Gynecol (1992) 1.01
The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with pre-eclampsia. BJOG (2010) 1.01
Outcome of the Vaginal Infections and Prematurity Study: results of a clinical trial of erythromycin among pregnant women colonized with group B streptococci. Am J Obstet Gynecol (1995) 1.00
Predictors of vaginal delivery in patients with a previous cesarean section, who require oxytocin. Am J Obstet Gynecol (1987) 0.99
Endometrial culture techniques in puerperal patients. Obstet Gynecol (1983) 0.98
Multicenter comparison of cefotetan and cefoxitin in the treatment of acute obstetric and gynecologic infections. Am J Obstet Gynecol (1988) 0.96
Puerperal infection in the antibiotic era. Am J Obstet Gynecol (1976) 0.95
A microbiologic and clinical study of placental inflammation at term. Obstet Gynecol (1987) 0.95
Assessment of office-based care of sexually transmitted diseases and vaginitis and antibiotic decision-making by obstetrician-gynecologists. Infect Dis Obstet Gynecol (1998) 0.95
Bacteremia in obstetrics: clinical course. Obstet Gynecol (1981) 0.95
Cefamandole therapy of endomyometritis following cesarean section. Am J Obstet Gynecol (1980) 0.94
A rabbit model for bacteria-induced preterm pregnancy loss. Am J Obstet Gynecol (1990) 0.93
Randomized comparison of ampicillin-sulbactam to cefoxitin and doxycycline or clindamycin and gentamicin in the treatment of pelvic inflammatory disease or endometritis. Obstet Gynecol (1994) 0.92
Management of acute chorioamnionitis. Am J Obstet Gynecol (1980) 0.92
Antibodies to Chlamydia trachomatis and risk for tubal pregnancy. Am J Obstet Gynecol (1988) 0.92
Standardizing the expression and nomenclature of cancer treatment regimens. American Society of Health-System Pharmacist (ASHP), American Medical Association (AMA), American Nurses Association (ANA). Am J Health Syst Pharm (1998) 0.92
Infections following classical cesarean section. Obstet Gynecol (1980) 0.91
A double-blind, randomized comparison of moxalactam versus clindamycin-gentamicin in treatment of endomyometritis after cesarean section delivery. Am J Obstet Gynecol (1983) 0.90
Serum gentamicin levels in patients with post-cesarean endomyometritis. Obstet Gynecol (1983) 0.90
Acute intrauterine infection results in an imbalance between pro- and anti-inflammatory cytokines in the pregnant rabbit. Am J Reprod Immunol (2000) 0.90
The course of labor in term patients with chorioamnionitis. Am J Obstet Gynecol (1983) 0.90
Streptococcal infections in pregnancy. A study of 48 bacteremias. Am J Obstet Gynecol (1981) 0.90
Mycoplasma hominis and intrauterine infection in late pregnancy. Sex Transm Dis (1984) 0.90
Correlation of quantitative amniotic fluid cultures with endometritis after cesarean section. Am J Obstet Gynecol (1982) 0.89
Paclitaxel (taxol). Pharmacotherapy (1994) 0.88
Bacteriologic effects of antibiotic prophylaxis in high-risk cesarean section. Obstet Gynecol (1981) 0.88
Further studies on genital mycoplasmas in intra-amniotic infection: blood cultures and serologic response. Am J Obstet Gynecol (1986) 0.87
Acute intraamniotic infection due to Streptococcus pneumoniae. Obstet Gynecol (1983) 0.87
Microbiologic and serologic studies of Gardnerella vaginalis in intra-amniotic infection. Obstet Gynecol (1987) 0.87
Effect of amniotic fluid bacteria on the course of labor in nulliparous women at term. Obstet Gynecol (1986) 0.86
A randomized, blinded, placebo-controlled trial of antibiotics in idiopathic preterm labor. Obstet Gynecol (1989) 0.86
A prospective, controlled study of maternal and perinatal outcome after intra-amniotic infection at term. Am J Obstet Gynecol (1983) 0.86
Administration of pentosan polysulfate to patients with human immunodeficiency virus-associated Kaposi's sarcoma. J Natl Cancer Inst (1993) 0.85
Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas. J Clin Oncol (1995) 0.85
Transmission of genital mycoplasmas from mother to neonate in women with prolonged membrane rupture. Pediatr Infect Dis J (1989) 0.85
Appropriate use of antibiotics in serious obstetric and gynecologic infections. Am J Obstet Gynecol (1983) 0.84
A rabbit model for ascending infection in pregnancy: intervention with indomethacin and delayed ampicillin-sulbactam therapy. Am J Obstet Gynecol (1993) 0.84
Management of premature rupture of membranes and unfavorable cervix in term pregnancy. Obstet Gynecol (1984) 0.84
A rabbit model for bacterially induced preterm pregnancy loss: intervention studies with ampicillin-sulbactam. Am J Obstet Gynecol (1991) 0.84
Randomized comparison of ceftazidime versus clindamycin-tobramycin in the treatment of obstetrical and gynecological infections. Antimicrob Agents Chemother (1983) 0.84
Women's reasons for not seeking prenatal care: racial and ethnic factors. Birth (1995) 0.84
A comparison of intrapartum versus immediate postpartum treatment of intra-amniotic infection. Obstet Gynecol (1987) 0.84
The effect of timing of single-dose transplacental ampicillin-sulbactam therapy for prevention of neonatal group B streptococcal colonization and bacteremia in a rabbit model. Am J Obstet Gynecol (1996) 0.83
A case-control study of wound abscess after cesarean delivery. Obstet Gynecol (1983) 0.83
Prevalence of asymptomatic hepatitis B infection in pregnant Mexican-American women. Obstet Gynecol (1990) 0.82
A controlled study of genital mycoplasmas in amniotic fluid from patients with intra-amniotic infection. J Infect Dis (1983) 0.82
Neonatal serologic response at term to the genital mycoplasmas. Pediatr Infect Dis J (1989) 0.82
The effect of internal fetal monitoring on maternal infection following cesarean section. Obstet Gynecol (1976) 0.82
A follow-up study on prophylactic antibiotics in cesarean section. Am J Obstet Gynecol (1973) 0.82
Animal models of ascending genital-tract infection in pregnancy. Infect Dis Obstet Gynecol (1994) 0.82
A randomized trial of conjugated group B streptococcal type Ia vaccine in a rabbit model of ascending infection. Am J Obstet Gynecol (1999) 0.81
Double-Blind Placebo-Controlled Treatment Trial of Chlamydia trachomatis Endocervical Infections in Pregnant Women. Infect Dis Obstet Gynecol (1997) 0.81
A pure enterococcal abscess after cesarean section. J Reprod Med (1977) 0.81
Moxalactam for treatment of pelvic infections after cesarean delivery. Rev Infect Dis (1983) 0.81
Ascending group B streptococcal genital infection in the rabbit model. Am J Obstet Gynecol (1996) 0.81
Previous intra-amniotic infection as a risk factor for subsequent peripartal uterine infections. Obstet Gynecol (1989) 0.80
The role of the newer antimicrobial agents in obstetrics and gynecology. Clin Obstet Gynecol (1988) 0.79
Piperacillin versus clindamycin plus gentamicin for pelvic infections. Obstet Gynecol (1984) 0.79
A randomized, double-blind, placebo-controlled trial of oral antibiotic therapy following intravenous antibiotic therapy for postpartum endometritis. Obstet Gynecol (1991) 0.79
Ondansetron: a serotonin receptor (5-HT3) antagonist for antineoplastic chemotherapy-induced nausea and vomiting. DICP (1991) 0.79
A randomized controlled trial of interleukin-1 receptor antagonist in a rabbit model of ascending infection in pregnancy. Infect Dis Obstet Gynecol (2001) 0.79
Enterococci in post-cesarean endometritis. Obstet Gynecol (1988) 0.79